Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

Abstract

This study was designed to test the hypothesis that T-cell effector mechanisms are required for protective immunity to malaria sporozoites. Administration of neutralizing monoclonal antibodies against γ interferon (γIFN) to immune hosts, reversed sterile immunity to sporozoite challenge, by allowing the growth of exoerythrocytic forms (EEF) and thus the development of parasitaemia. Immune animals also developed infections when depleted in vivo of their suppressor/cytotoxic T cells expressing the CD8 antigen (CD8+) but not when depleted of helper T cells expressing CD4 antigen (CD4+), before sporozoite challenge. Passive transfer of immune immunoglobin alone, or adoptive transfer of immune T cells alone, conferred partial protection to naive recipients. Transfer of both immune components resulted in significantly greater protection. This transferred immunity was reversed by the in vivo neutralization of γIFN. Thus, sterile immunity to sporozoite challenge requires the neutralization of sporozoites by antibodies and the inhibition of EEF development by γIFN with the participation of CD8+ cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. 1. Nussenzweig, R. & Nussenzweig, V. Phil Trans R. Soc. B307, 117-128 (1984). 2. Zavala, F., Cochrane, A., Nardin, E., Nussenzweig, R. & Nussenzweig, V. J. exp. Med. 157, 1947-1957 (1983). 3. Potocjnack, P., Yoshida, N., Nussenzweig, R. & Nussenzweig, V. J. exp. Med. 151,1504-1513 (1980). 4. Hollingdale, M., Zavala, F., Nussenzweig, R. & Nussenzweig, V. J. Immun. 128, 1929-1930 (1982). 5. Chen, D., Tigelaar, R. & Weinbaum, F. /. Immun. 118, 1322-1327 (1977). 6. Ferreira, A. et al. Science 232, 881-884 (1986). 7. Maheshwari, R. et al. Infect. Immunity 53, 628-630 (1986). 8. Schofield, L., Ferreira, A., Altszuler, R., Nussenzweig, V. & Nussenzweig, R. S. J. Immun. 139,2020-2025 (1987). 9. Van Der Meide, P. et al. J. gen. Virol. 67, 1059 (1986). 10. Ferreira, A., Enea, V., Morimoto, T. & Nussenzweig, V. Molec. Biochem. Parasitol. 19, 103-109 (1986). 11. Shin, S.. Vanderberg, J. & Terzakis, J. / Protozool. 29(3), 448-454 (1982). 12. Hamilton Fairley, N. Trans. R. Soc. trap. Med. Hyg. 40, 621-676 (1947). 13. Cobbold, S., Jayasuriya, A., Nash, A., Prospero, T. & Waldmann, H. Nature 312, 548-551 (1984). 14. Verhave, J., Strickland, G., Jaffe, H. & Ahmad, A. J. Immun. 121, 1031-1033 (1978). 15. Egan, J. et al. Science 236, 453-456 (1987). 16. Zavala, F. et al. J. exp. Med. 166, 1591-1596 (1987). 17. Good, M. et al. Science 235, 1059-1062 (1976). 18. Good, M. et al. J. exp. Med. 164, 655-660 (1986). 19. Del Guidice, G. et al. J. Immun. 137, 2952-2955 (1986). 20. Togna, A. et al. J. Immun. 137, 2956-2960 (1986).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schofield, L., Villaquiran, J., Ferreira, A. et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664–666 (1987). https://doi.org/10.1038/330664a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/330664a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing